83 related articles for article (PubMed ID: 8924370)
1. Mobilized peripheral blood transplants may overtake ABMT within two years.
Oncology (Williston Park); 1995 Jul; 9(7):597. PubMed ID: 8924370
[No Abstract] [Full Text] [Related]
2. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
3. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
Watt SM; Austin E; Armitage S
Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
[TBL] [Abstract][Full Text] [Related]
4. Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
Lobo F; Kessinger A; Landmark JD; Smith DM; Weisenburger DD; Wigton RS; Armitage JO
Bone Marrow Transplant; 1991 Nov; 8(5):389-92. PubMed ID: 1685105
[TBL] [Abstract][Full Text] [Related]
5. Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: implications for marrow reconstitution and the use of thrombopoietin.
Richards EM; Jestice HK; Mahendra P; Scott MA; Marcus RE; Baglin TP
Bone Marrow Transplant; 1996 Jun; 17(6):1029-33. PubMed ID: 8807110
[TBL] [Abstract][Full Text] [Related]
6. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.
To LB; Roberts MM; Haylock DN; Dyson PG; Branford AL; Thorp D; Ho JQ; Dart GW; Horvath N; Davy ML
Bone Marrow Transplant; 1992 Apr; 9(4):277-84. PubMed ID: 1350938
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
[TBL] [Abstract][Full Text] [Related]
8. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
9. Human hematopoietic progenitor in bone marrow and peripheral blood.
Messner HA
Stem Cells; 1998; 16 Suppl 1():93-6. PubMed ID: 11012151
[TBL] [Abstract][Full Text] [Related]
10. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Pession A; Rondelli R; Paolucci P; Pastore G; Dini G; Bonetti F; Madon E; Mandelli F; Zanesco L; Uderzo C; Prete A; Rabusin M; Ugazio A; Di Bartolomeo P; Favre C; Bojd-Faulkner L; Poggi V; Luksch R; Donfrancesco A; Argiolu F; La Nasa G; Amici A; Locatelli F
Haematologica; 2000 Jun; 85(6):638-46. PubMed ID: 10870122
[TBL] [Abstract][Full Text] [Related]
12. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
13. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
[TBL] [Abstract][Full Text] [Related]
14. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
[TBL] [Abstract][Full Text] [Related]
15. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation in acute leukemia.
Gorin NC
J Natl Cancer Inst; 1986 Jun; 76(6):1281-7. PubMed ID: 2940400
[TBL] [Abstract][Full Text] [Related]
17. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
18. Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.
Beaujean F; Hartmann O; Benhamou E; Lemerle J; Duedari N
Bone Marrow Transplant; 1989 Sep; 4(5):537-41. PubMed ID: 2790332
[TBL] [Abstract][Full Text] [Related]
19. [Haematopoietic stem cell specimens].
Le Berre C
Transfus Clin Biol; 2005 Jun; 12(2):160-2. PubMed ID: 15894510
[No Abstract] [Full Text] [Related]
20. Blood cell transplantation: report from an International Consensus Meeting.
Juttner CA; Fibbe WE; Nemunaitis J; Kanz L; Gianni AM
Bone Marrow Transplant; 1994 Nov; 14(5):689-93. PubMed ID: 7889001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
